	Hinokitiol identified from Phyllanthus fraternus leaves a potential therapeutic solution for hepatocellular carcinoma: a network pharmacology-based study. In Silico Pharmacol Upadhyay R, Kumar P, Yadav P, Yadav MK, Tiwari KN. PMID: 42389725 [PubMed]
	Innovations in HPV vaccination and their role in global cervical cancer control: a review. Ther Adv Vaccines Immunother H Chuwa A. PMID: 42389684 [PubMed - in process]
	RETRACTION: Thujone-Rich Fraction of Thuja occidentalis Demonstrates Major Anti-Cancer Potentials: Evidences from In Vitro Studies on A375 Cells. Evid Based Complement Alternat Med And Alternative Medicine EC. PMID: 42389676 [PubMed - in process]
	Bioengineering advances in pancreatic cancer organoids for reproducible tumor microenvironment modeling. iScience Chen R, Yin B, Zhang Y, Peng J, Guo X, Wu W. PMID: 42389605 [PubMed - in process]
	Tumor treating fields combined with concurrent chemoradiotherapy for glioblastoma: A multi-institutional analysis. iScience Zhai M, Hu G, Shen G, Zhong Y, Huang J, Li Q, Liang L, Huang Y, Bi J, Li Y, Li Y, Pi G, Shi H, He H, Verma V, Wang Y, Han G. PMID: 42389573 [PubMed - in process]
	A scoping review on pathways/models/frameworks for palliative care provision for cancer patients while admitted at hospitals within sub-Saharan Africa. Ecancermedicalscience Tererai AC, Borok M, Chirenje ZM, Gwyther L, Farrant L, Ndlovu N, Rusakaniko S. PMID: 42389564 [PubMed - in process]
	Cost-effectiveness and budget impact of breast cancer genetic profiling in Egypt. Ecancermedicalscience Kotb A, Hassan WA. PMID: 42389563 [PubMed - in process]
	Validation of Onco-MPI and Geriatric-8 for predicting 2-year mortality in older Indian patients with breast cancer: a prospective observational study. Ecancermedicalscience Sable S, Wadasadawala T, Kannan M, Sarin R, Pathak R, Krishnamurthy R, Gulia S, Joshi S, Popat P, Shet T. PMID: 42389560 [PubMed - in process]
	Editorial: Immune-related biomarkers in skin and breast cancer: innovations in immunological diagnostics and therapies. Front Immunol Mallardo D, Ottaviano M, Palmieri G, Melucci MT. PMID: 42389541 [PubMed - in process]
	Reprogramming dendritic cells to overcome tumor-mediated immune suppression. Front Immunol Malik JA. PMID: 42389537 [PubMed - in process]
	A transcriptome-defined TAM-rich phenotype identifies a macrophage-enriched, hypoxia-linked immune contexture in glioblastoma: multi-cohort transcriptomic validation and local histopathological correlation. Front Immunol Li G, Yan X, Fang S. PMID: 42389535 [PubMed - indexed for MEDLINE]
	Fusion protein-mediated costimulation in engineered T cells: from intrinsic signaling to tumor microenvironment rewiring. Front Immunol Toumi R, Guenette SJ, Oda SK. PMID: 42389526 [PubMed - in process]
	The regulatory roles of dysregulated lactate dehydrogenase A in anti-tumor immunity within immune cells. Front Immunol Song X, Lin S, Liu Q, Chen X, Ma Y, Zhang X, Ren F. PMID: 42389525 [PubMed - indexed for MEDLINE]
	Correction: MAPRE2 is associated with macrophage-enriched innate immune dysregulation and malignant phenotypes in hepatocellular carcinoma. Front Immunol An X, Gao Y, Zhao S, He W, Yang X, Wu Y, Li J, Yi R, Han Y, Li M, Li Q, Yang T. PMID: 42389514 [PubMed - in process]
	Epstein-Barr virus-driven immunosuppression in nasopharyngeal carcinoma: a comprehensive review of viral mechanisms, spatial tumor ecosystems, and precision therapeutics. Front Immunol Qu H, Zhang P, Tang Y, Chang T. PMID: 42389513 [PubMed - in process]
	Halogenated anthraquinones in breast cancer therapy: Structural modifications targeting VEGF-related angiogenesis pathways. J Pharm Anal Zhou C, Sarian MN, Tong X, Han R, Anasamy T, Hamezah HS. PMID: 42389487 [PubMed - in process]
	Immunocyte senescence: A new perspective on the remodeling of the ovarian cancer microenvironment and therapeutic intervention. J Pharm Anal Li X, Li X, Ni S, Zhang X, Liu B. PMID: 42389486 [PubMed - in process]
	Unveiling the comorbidity hub: WT1 drives renal cancer progression in chronic kidney disease and confers sirolimus vulnerability. Exp Ther Med Zhang W, Tang P, Wu S, Sui Z. PMID: 42389452 [PubMed - in process]
	Molecular residual disease-based novel modality of postoperative management for non-small-cell lung cancer (REMODEL): Protocol for a prospective multicenter study. J Transl Int Med Yuan X, Jin R, Wei Y, He Y, Weng L, Li Z, Wang JA, Li X, Xu J, Bai J, Wang Y, Zhang Q, Zhou N, Hou Y, Wang G, Zhang J, Yin R, Li Z, Li Y, Yang F, Wang J, Chen K, REMODEL Study. PMID: 42389426 [PubMed - in process]
	Prehabilitation in lung cancer patients undergoing lung resection surgery (Fit4LungNeo): study protocol. Contemp Clin Trials Commun Guedes da Silva DP, Bohn L, Oliveira J, Eusébio E, Fernandes MG, Teixeira C, Canelas H, Fernandes P, Leite-Moreira A, Gonçalves L, Godinho AS, Monteiro JL, Kendall F. PMID: 42389378 [PubMed - in process]

Articles 1 - 20 / 1951712

Page 1 of 97586



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy